𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inactivation by the mitotic inhibitor NY 3170 of human cells in vitro

✍ Scribed by Wibe, E; Oftebro, R

Book ID
109834877
Publisher
Nature Publishing Group
Year
1979
Tongue
English
Weight
771 KB
Volume
40
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Inactivation of human cells cultivatedin
Inactivation of human cells cultivatedin vitroby the new mitotic inhibitors NY 4137 and NY 4138
✍ Mina E. Holm Nygaard; Erik O. Pettersen; John M. Dornish; Kjell Undheim; Reidar πŸ“‚ Article πŸ“… 1987 πŸ› Springer US 🌐 English βš– 582 KB

The effect of the two closely related drugs, the sulfone 2-(2-thenyl)sulfonyl-5-bromopyrimidine (NY 4137), and the sulfoxide 2-(2-thenyl)sulfinyl-5-bromopyrimidine (NY 4138), a sulfoxide, on the survival of cells of the human line NHIK 3025 was investigated. Cell survival was measured as the ability

Effects of the new mitotic inhibitor pyr
Effects of the new mitotic inhibitor pyrimidinsulfone NY 4137 on human cells in vitro and on colchicine binding to tubulin
✍ Mina E. Holm Nygaard; John M. Dornish; Reidar Oftebro; Kjell Undheim πŸ“‚ Article πŸ“… 1986 πŸ› Springer US 🌐 English βš– 948 KB

The effect of 2-(2-thenyl)sulfonyl-5-bromopyrimidine (NY 4137) on cells of the human line NHIK 3025 was investigated. It was shown that NY 4137 induces cell cycle specific inhibition in metaphase. A dose-dependent prolongation of metaphase was found and the fraction of cells able to escape metaphase

Reduced mitotic activity at the peripher
Reduced mitotic activity at the periphery of human embryonic stem cell colonies cultured in vitro with mitotically-inactivated murine embryonic fibroblast feeder cells
✍ Boon Chin Heng; Tong Cao; Hua Liu; Abdul Jalil Rufaihah πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 316 KB

## Abstract This study attempted to investigate whether different levels of mitotic activity exist within different physical regions of a human embryonic stem (hES) cell colony. Incorporation of 5‐bromo‐2‐deoxyuridine (BrdU) within newly‐synthesized DNA, followed by immunocytochemical staining was